Upload Avatar (500 x 500)
Min Peng
Medical School
Wuhan University
Hubei
Language: English, Chinese
Lung Cancer
Diagnosis
Treatment
Clinical Research
Immunotherapy
Oncology
Cancer Therapy
Clinical Trials
Biomedical Research
Translational Research
Areas of Focus
- Lung cancer diagnosis and treatment
- Tumor immunotherapy
Work Experience
- 2010.07-2014.11: Attending Physician at Oncology Center, Renmin Hospital, Wuhan University
- 2014.12-2017.09: Associate Professor and Vice Chief Physician at Oncology Center, Renmin Hospital, Wuhan University
- 2017.10-present: Vice Director at Oncology Department, East Hospital District, Renmin Hospital, Wuhan University
- 2019.11-present: Chief Physician at Oncology Center, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 1999-2004: Bachelor's Degree from Wuhan University Medical School
- 2004-2010: PhD from Wuhan University Medical School (Joint training with the USA)
- Received 2 National Natural Science Foundation grants
- Received 2 provincial science and technology department and health department items
Publications
- Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis, Yao Jin, Aili Tan, Jia Feng, Zexi Xu, Peiwei Wang, Peng Ruan, Ruijun Luo, Yiming Weng, Min Peng, 2021
- Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis, Xu Zexi, Feng Jia, Weng Yiming, Jin Yao, Peng Min, 2021
- BMP2K dysregulation promotes abnormal megakaryopoiesis in acute megakaryoblastic leukemia, Manman Wang, Tan Zhang, Xuechun Zhang, Zhou Jiang, Min Peng, Zan Huang, 2020
- Effects of HER2 status on the prognosis of male breast cancer: a population-based study, Liang Chen, Yi Ming Weng, Meng Xue Hu, Min Peng, Qi Bin Song, 2019
- Prion Protein Protects Cancer Cells against Endoplasmic Reticulum Stress Induced Apoptosis, Gao Z, Peng M, Chen L, Yang X, Li H, Shi R, Wu G, Cai L, Song Q, Li C, 2019
- Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples, Yi Yao, Min Peng, Qinglin Shen, Qinyong Hu, Hongyun Gong, Qingqing Li, Zhongliang Zheng, Bin Xu, Yingge Li, Yi Dong, 2019
- The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis, Min Peng, Xing Li, Gu Lei, Yi Ming Weng, Meng Xue Hu, Qi Bin Song, 2018
- Clinical and molecular characteristics associated with the efficacy of PD-1/PD-L1 inhibitors for solid tumors: a meta-analysis, Yi Ming Weng, Min Peng, Meng Xue Hu, Yi Yao, Qi Bin Song, 2018
- Clinical characteristics and survival outcomes for non-small cell lung cancer patients with epidermal growth factor receptor double mutations, Peng M., Weng Y., Liu H., Yang G., Yao Y., Han G., Song Q., 2018
- Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in nonsmall cell lung cancer, Chen L., Peng M., Li N., Song Q., 2018
- Nicotinamide-based diamides derivatives as potential cytotoxic agents: synthesis and biological evaluation, Peng M., Shi L., Ke S., 2017
- The Cytotoxic Effect of GW843682X on Nasopharyngeal Carcinoma, Hu Q, Chu Y, Hu W, Peng M, Song Q, 2016
Awards
- 2020: Second Prize of Hubei Province Science and Technology for 'Innovation and Application of Targeted and Intelligent Radiotherapy Quality Control System'
